Thackray Helen M. - Insider Non-Derivative Transactions at BIOCRYST PHARMACEUTICALS INC (BCRX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on May 14, 2024, Thackray Helen M.'s relationship to BIOCRYST PHARMACEUTICALS INC (BCRX) is Officer (Chief R&D Officer), and currently has 272,139 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other BCRX insiders.
Data Source: SEC.
Thackray Helen M. - Insider Non-Derivative Transactions of BCRX Common Stock
Thackray Helen M. - Insider Non-Derivative Transactions at BCRX
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| May 15, 2024 | P -- (Common Stock) | 30000 | 5.86 | 272139 |
| Apr 1, 2024 | F -- (Common Stock) | 7525 | 5.08 | 242139 |
| Dec 20, 2023 | F -- (Common Stock) | 5580 | 6.05 | 249664 |
| Dec 15, 2023 | F -- (Common Stock) | 3031 | 6.43 | 255244 |
| Dec 15, 2023 | Acquisition -- (Common Stock) | 51000 | 0 | 258275 |
| Apr 4, 2023 | Sell -- (Common Stock) | 7000 | 8.29 | 207275 |